• DiscoveryProbe Metabolism-related Compound Library: Applied

  2026-06-07

  The DiscoveryProbe™ Metabolism-related Compound Library empowers researchers to dissect complex metabolic pathways with rigorously validated, cell-permeable small molecules. Streamline enzyme inhibition assays, pathway elucidation, and translational research on metabolic diseases and cancer, all with ready-to-use 10 mM DMSO solutions and robust troubleshooting strategies.

• Targeted EPO mRNA Nanoparticles Suppress Ferroptosis in SCI

  2026-06-06

  A recent study introduces a mannose-modified nanoparticle system to deliver human erythropoietin mRNA directly to inflammatory macrophages at spinal cord injury sites. This targeted approach enables local EPO protein production, attenuating neuroinflammation and ferroptosis and improving neurological recovery, with broad implications for mRNA-based neurorepair strategies.

• Bismuth Subsalicylate in GI Disorder Research: Applied Workf

  2026-06-05

  Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) enables robust, reproducible gastrointestinal disorder research by targeting prostaglandin-mediated inflammation. This article delivers actionable protocols, troubleshooting strategies, and a synthesis of membrane biology tools to maximize translational insight using APExBIO’s high-purity reagent.

• Minoxidil Sulphate: Insights into Potassium Channel Modulati

  2026-06-05

  Explore the role of Minoxidil sulphate in vascular and renal research, with a focus on potassium channel modulation and protocol optimization. This article delivers advanced, evidence-based insights distinct from existing guides on this high-purity research compound.

• Ibuprofen in Cancer Research: Beyond Protocols to Mechanisti

  2026-06-04

  Explore how Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) advances colon cancer research through dual COX inhibition, apoptosis induction, and unique molecular mechanisms. This article offers a deeper, evidence-based perspective for translational oncology workflows.

• Ouabain: Selective Na+/K+-ATPase Inhibitor in Cardiovascular

  2026-06-04

  Ouabain stands out as a gold-standard selective Na+/K+-ATPase inhibitor, enabling precise dissection of ion transport and cardiac signaling in both cell-based and animal models. This article details hands-on workflows, troubleshooting strategies, and the translational edge that APExBIO's ouabain brings to advanced cardiovascular and cellular physiology research.

• Ziprasidone Hydrochloride: Nanocrystal Innovations in Oncolo

  2026-06-03

  Explore how ziprasidone hydrochloride nanocrystals are transforming dopaminergic and serotonergic pathway research, with breakthrough insights for oncology and neuroscience applications. This article uniquely unpacks permeability, formulation, and translational assay design.

• KN-62: Precision CaMKII Inhibition for Calcium Signaling Stu

  2026-06-03

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, unlocks targeted inhibition of CaMKII for dissecting calcium signaling, metabolic regulation, and cell cycle dynamics in advanced research. Its robust selectivity and proven efficacy streamline workflows in neurobiology, cancer, and metabolic studies, with APExBIO ensuring reagent reliability.

• Morning Training Enhances Endurance Adaptation in Mice

  2026-06-02

  Hesketh et al. reveal that endurance training during the early active (morning) phase leads to greater performance improvements in mice compared to identical training in the afternoon. This study clarifies the biological relevance of exercise timing, with direct implications for experimental design in circadian, metabolic, and exercise adaptation research.

• Dual-Action p38α MAPK Inhibitors Accelerate Dephosphorylatio

  2026-06-02

  The referenced study reveals that certain p38α MAPK inhibitors not only block kinase activity but also promote phosphatase-mediated dephosphorylation by stabilizing a kinase conformation accessible to phosphatases. This dual-action mechanism has direct implications for designing more selective and potent kinase inhibitors, with translational relevance in inflammation, oncology, and cellular signaling research.

• MPC Downregulation, Lactate, and Histone Lactylation in Tumo

  2026-06-01

  This study uncovers how mitochondrial pyruvate carrier (MPC) downregulation in colorectal cancer elevates lactate production, driving histone lactylation in dendritic cells and thereby impeding anti-tumor immune responses. These findings clarify a metabolic-epigenetic axis that influences immunotherapy efficacy, highlighting avenues for targeting lactate metabolism in the tumor microenvironment.

• TCF25 Orchestrates Lysosomal Cell Death Under Glucose Starva

  2026-06-01

  Ren et al. (2025) identify TCF25 as a critical nutrient sensor that regulates metabolic adaptation and induces lysosome-dependent cell death during glucose starvation by enhancing lysosomal acidification and ferritinophagy. These findings clarify key mechanisms underlying cellular responses to energy stress and suggest new targets for managing metabolic and ischemic disorders.

• Moxifloxacin: Fluoroquinolone Antibiotic Workflows & Insight

  2026-05-31

  Moxifloxacin stands out as a broad-spectrum fluoroquinolone antibiotic, enabling robust research into DNA gyrase inhibition, antibiotic toxicity, and metabolic modulation at the cellular and animal levels. This article details advanced experimental workflows, troubleshooting strategies, and the translational significance of APExBIO’s Moxifloxacin for next-generation research.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Us

  2026-05-30

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe provides robust, high-contrast plasma membrane labeling in live or fixed samples, supporting workflows such as neuronal tracing and cell migration assays. It is not suitable for water-based protocols or for exclusive organelle labeling, and careful attention to solvent choice and membrane integrity is required for optimal results.

• Nilotinib (AMN-107): Precision Tools for Ribosome Stress Pat

  2026-05-29

  Explore how Nilotinib (AMN-107) empowers advanced chronic myeloid leukemia research and BCR-ABL pathway interrogation, with a novel focus on ribosome collision signaling. Discover deep mechanistic insights and protocol guidance not found in standard guides.

444 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page